Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma-Reference-Cited by-同舟云学术

Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma

Published:2019-03 Issue:6 Volume:58 Page:1056-1067
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Mol Carcinog

Author:

Zhao Zhenjiang¹²,Jin Guoguo¹²,Yao Ke¹²,Liu Kangdong¹³⁴,Liu Fangfang⁴,Chen Hanyong¹²,Wang Keke⁴,Gorja Dhilli Rao⁴,Reddy Kanamata¹,Bode Ann M.¹,Guo Zhiping²,Dong Zigang¹⁴^ORCID

Affiliation:

1. The Hormel Institute, University of MinnesotaAustin Minnesota

2. Henan Provincial Orthopedic HospitalZhengzhou Henan People's Republic of China

3. Department of PathophysiologySchool of Basic Medical Sciences, Zhengzhou UniversityZhengzhou Henan People's Republic of China

4. China‐US (Henan) Hormel Cancer InstituteZhengzhou Henan People's Republic of China

Funder

National Natural Science Foundation of China

Foundation for the National Institutes of Health

Mayo Clinic

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.22993

Reference38 articles.

1. Translational biology of osteosarcoma

2. Incidence and survival of malignant bone sarcomas in England 1979-2007

3. Pediatric surface osteosarcoma: Clinical, pathologic, and radiologic features

4. The Epidemiology of Osteosarcoma

5. Chemotherapy resistance in osteosarcoma: current challenges and future directions

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Aurora-B: a novel biomarker in the invasion and metastasis of osteosarcoma;Biomarkers in Medicine;2024-07-17

3. Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway;Frontiers in Oncology;2024-07-02

4. From biology to personalized medicine: Recent knowledge in osteosarcoma;European Journal of Medical Genetics;2024-06

5. Unveiling the Anticancer Mechanisms of Prodigiosin by inhibiting of CDK1, TOP2A, and AURKB Expression in Cervical Carcinoma;2024-01-25